Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Endocrine > DM- Management Part 2 - Exam 4 > Flashcards

DM- Management Part 2 - Exam 4 Flashcards

1
Q

What is the MOA of insulin? How is it classified?

A

mimics the effect of regular insulin.

Classified by time of onset and duration of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which type of insulin is considered to have less ideal timing and is less expensive

A

Non-analog insulins (regular, NPH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are common SE of insulin? What is the major one?

A

hypoglycemia**- MC
weight gain
inflammation
fibrosis
pain
lipohypertrophy
lipoatrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How are insulin pens dosed? What effect does alcohol have?

A

dosed in units

Alcohol - often causes hypoglycemia in insulin-dependent patients!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the 3 rapid acting insulins?

A

Insulin lispro (Humalog) / Insulin lispro-aabc (Lyumjev) - U100, U200

Insulin aspart (Novolog) / Insulin faster aspart (Fiasp)

Insulin glulisine (Apidra)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the rapid acting inhaled insulin?

A

Technosphere insulin (Afrezza)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

______ is the short acting insulin

A

Human regular (Humulin R, Novolin R) - U100, U500

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

_____ is the intermediate acting insulin

A

Human NPH (Humulin N, Novolin N)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the 4 long acting insulin? Which 2 are ultra long?

A

Insulin detemir (Levemir)
Insulin glargine U100 (Lantus)

Ultra long:
Insulin glargine U300 (Toujeo) - ultra-long
Insulin degludec (Tresiba) - U100, U200 - ultra-long

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

**When is inhaled insulin CI? What are the major SE? What are the monitor requirements?

A

not for use in smokers or pts with chronic lung conditions

cough; possible increased risk of lung cancer

requires periodic PFTs - baseline, 6 mo, then yearly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the major advantages of premixed insulin?

A

advantage: fewer injections

disadvantage: less ability to adjust dose. NPH insulin can be harder to predict

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Where are some common insulin injections site? What is the pt education?

A

arms, abdomen and thighs

need to rotate within each site but need to keep it within the site due to how the body metabolizes it to keep the dose steady

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

If the pt is carb counting, what is the recommended carb intake for males and females? meals and snack

What is the insulin recommendation?

A

Males - 60 g per meal, 30 g per snack
Females - 45 g per meal, 15 g per snack

1 U per 15 g of carbohydrate, PLUS
1 U for every 50 mg/dL of BG at pre-meal screening above a set goal (i.e., 120 mg/dL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the dawn phenomenon? How do you correct it?

A

hyperglycemia in the morning

Nocturnal release of counterregulatory hormones (glucagon, epinephrine, cortisol) leads to increased glucose levels

Inadequate levels of insulin to balance increased glucose leads to AM hyperglycemia

“Down Insulin” -> need to increase insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the Somogyi Effect? How do you correct it?

A

due to excess amounts of exogenous insulin with evening dose

pt becomes hypoglycemic while sleeping and the body releases counterregulatory hormones

increased glucose levels in the AM leads to rebound hyperglycemia

“so much insulin”-> need to decrease insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which cause of hyperglycemia in the morning, leads to the sugar bottoming out in the middle of the night?

A

somogyi effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How do you tell the difference between the dawn phenomenon and somogyi effect? What do you expect for each?

A

Have patient wake up a few nights in a row to check his/her sugar at 3 am

Low readings - Somogyi Effect
Medium-high readings - Dawn Phenomenon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the Professor Jensen way to tell the difference between dawn phenomenon and somogyi effect? What do you expect for each?

A

try decreasing evening/bedtime dose of insulin

Hyperglycemia improves - Somogyi Effect
Hyperglycemia persists or worsens - Dawn Phenomenon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

**If you are unsure if its the dawn phenomenon and somogyi effect, what should you NOT do?

A

If you aren’t sure - don’t increase insulin dose!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the general guidelines for a T1DM insulin dosing schedule?

A

Starting calculation of 0.5 U/kg - divided into two portions
50% - basal (long-acting) insulin dose
50% - bolus (rapid-acting or short-acting) - divided into 3 equal parts

Requires 4 injections/day (3 rapid-acting or short-acting, 1 long-acting) should also check BS 3-4 times a day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the recommendations to adjust your bolus insulin?

A

If BS is under 80 need to subtract 2 units from the injection prior

80-130 keep insulin the same.

BS over 130, add to units to your previous insulin injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which is considered the better choice, long acting insulin or NPH? Why?

A

long acting is better because it has better predictable absorption and LESS hypoglycemia,

long acting is dosed QD

NPH is dosed BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Is rapid acting or regular insulin preferred? Why?

A

rapid acting is preferred because it has more predictable absorption
Shorter duration of action - less “leftover” hypoglycemia

regular: has less predictable absorption
but can give IV
more hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How many injections is premix dosing? How many BS checks?

A

BID

2-3 BG check a day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
How do you instruct a pt to start premix insulin?
26
When is sliding scale insulin commonly used? Why?
in pts setting Reactive approach to hyper- and hypoglycemia Often results in wide swings in glucose control does not address basal insulin needs, can use basal insulin alongside
27
_____ is an TNF-alpha inhibitor In animal trials, has shown improved β-cell function; may help both T1DM or T2DM
Infliximab (Remicade) \
28
______ MAb that binds to receptors on CD4+ and CD8+. Approved for pts 8 y/o and up who are at high risk for T1DM. What does it do overall? What are the SE?
Teplizumab mzwv (Tzield) Delays the onset of T1DM (2.5 yrs in clinical trials) and improves β-cell function transient leukopenia and lymphocytopenia; rash; headache
29
When is a pancreas transplant often recommended for a T1DM? What are the drawbacks?
Often recommended for patients who are also receiving renal transplant have to be on lifetime immunosuppression
30
______ “cellular therapy” rather than organ transplant Deceased donor pancreatic islet cells infused via the hepatic portal vein Allows for a less toxic immunosuppressive drug regimen
Donislecel-jujn (Lantidra)
31
What is the MOA of metformin? What is the drug class?
Inhibits hepatic gluconeogenesis helps "fix a leaky liver". Helps decrease intestinal absorption of glucose Slightly improves insulin sensitivity Increa drug class: Biguanides
32
Is metformin associated with hypoglycemia? What is the major SE? What is the BBW? Need to avoid use in what type of pts?
NOT associated with hypoglycemia GI SE: diarrhea BBW: lactic acidosis, Avoid in chronic renal failure (GFR <30mL), liver failure and excess alcohol intake
33
What is the MOA of Pioglitazone (Actos)? What line are they? What drug class?
“Unlock” muscle and fat cells to help them utilize glucose. -Improves insulin sensitivity -decreases gluconeogenesis - increases glucose uptake - increases adipogenesis 2nd or 3rd line Thiazolidinediones
34
______ bind a nuclear receptor called PPAR-gamma, which affects the expression of several genes relevant to glucose metabolism!
Pioglitazone (Actos) drug class: Thiazolidinediones
35
Is Pioglitazone (Actos) associated with hypoglycemia? What are the SE? What is the BBW?
NOT associated SE: weight gain, peripheral edema, BLADDER CANCER BBW: CHF
36
What DM med carries a increased risk for bladder cancer?
pioglitazone increases risk thiazolidinediones
37
Glimepiride (Amaryl) Glipizide (Glucotrol) Glyburide (DiaBeta, Micronase) What drug class? What is the MOA?
Sulfonylureas “Zap” the pancreas to stimulate increased production of insulin
38
Repaglinide (Prandin) Nateglinide (Starlix) What drug class? What is the MOA?
Meglitinides Repaglinide (Prandin) Nateglinide (Starlix)
39
______ bind to a site on the ATP-sensitive K+ channel of beta cells, leading in turn to depolarization, opening of voltage dependent Ca channels, and release of insulin
both Sulfonylurea and Meglitinide
40
Are Sulfonylurea/Meglitinide associated with hypoglycemia? What are the SE? Avoid use in what pt? Are they first line?
IS associated with hypoglycemia (but not as bad as insulin) SE: weight gain Patients with chronic liver disease or chronic renal failure may be poor candidates NOT first line
41
Acarbose (Precose) Miglitol (Glyset) What drug class? What is the basic MOA?
α-Glucosidase Inhibitors “Block” the breakdown of starches in the intestine by inhibiting the enzymes that breaks down starch and sucrose
42
Are α-Glucosidase Inhibitors associated with hypoglycemia? What are the SE? What are the CI?
NOT associated with hypoglycemia GI: flatulence, elevated LFTs, bloating, belly pain due to undigested starches CI: Diabetic ketoacidosis, Cirrhosis, Major chronic GI disease
43
Canagliflozin (Invokana) Dapagliflozin (Farxiga) Empagliflozin (Jardiance) Bexagliflozin (Brenzavvy) Ertugliflozin (Steglatro) What drug class? What is the basic MOA? What part of the tubule? Is it first line?
SGLT2 Inhibitors “Halt” renal glucose reabsorption ↑ glucose excretion by inhibiting protein that accounts for about 90% of glucose reabsorption in the kidney aka they pee out glucose Act on the proximal tubule Alternative first line therapy
44
_____ : blocks SGLT1 AND SGLT2; indicated for _____
Sotagliflozin (Inpefa) heart failure
45
Are SGLT2 inhibitors associated with hypoglycemia? **What are the SE? What are the CI? Are they used in T1DM?
NOT associated with hypoglycemia **GU - ↑ incidence of UTIs, genital mycotic infections. increases LDL, dehydration, may increase risk of DKA CI: Moderate-severe CKD NOT used in T1DM
46
SGLT2 inhibitor that is associated with bladder cancer? SGLT2 inhibitor that is associated with bone fractures and amputations?
bladder cancer: dapagliflozin bone fractures, amputations: canagliflozin
47
Exenatide (Byetta/Bydureon) Liraglutide (Victoza, Saxenda) Lixisenatide (Adlyxin) Dulaglutide (Trulicity) Semaglutide (Ozempic, Rybelsus) Tirzepatide (Mounjaro) What drug class? What is the basis MOA? Which one is available in oral form? Which one also acts as a GIP agonist?
GLP-1 Receptor Agonists mimic the incretin GLP-1 Semaglutide (Ozempic, Rybelsus* Tirzepatide (Mounjaro)**
48
What is the detailed MOA of GLP-1 Receptor Agonists?
↑ insulin release ↓ glucagon release ↓ gastric emptying ↑ satiety May ↑ beta-cell proliferation
49
______ may cause hypoglycemia if patient is also taking insulin secretagogues
GLP-1 Receptor Agonists
50
Are GLP-1 receptor agonists associated with hypoglycemia? What kind of pt would these meds be of considerable benefit? **What are some SE? What are the BBW?
Not associated with hypoglycemia NASH/NAFLD - May be helpful to reduce hepatic steatosis SE: dose dependent N/V/D BBW: thyroid cancer (especially medullary)
51
Which GLP-1 receptor has the highest GI SE?
Moujaro
52
Sitagliptin (Januvia) Saxagliptin (Onglyza) Linagliptin (Tradjenta) Alogliptin (Nesina) What drug class? What is the basic MOA? Is it first line?
DPP-4 Inhibitors “Stretch” out the effects of endogenous incretin GLP-1 by inhibiting the enzyme that degrades it good 2nd line drug!
53
Are DPP-4 Inhibitors associated with hypoglycemia? SE? What medication should not be prescribed at the same time?
NOT associated with hypoglycemia N/V/D - less than GLP-1 agonists, pancreatitis, increased risk of severe arthralgias Not indicated for co-treatment with GLP-1 agents
54
DPP-4 inhibitors: _____ and _____ have an alert for possible increased risk of heart failure
Alogliptin and Saxagliptin
55
Pramlintide (Symlin) What drug class? What is the basic MOA?
Amylin Analogs “Impersonate” the effects of amylin (synthetic amylin analog)
56
**What other drug besides insulin can be used in T1DM? (can also be used in T2DM) What form dose it come in?
Pramlintide (Symlin): Amylin Analogs SC injection
57
Does Amylin Analogs cause hypoglycemia? SE? What is the BBW?
SE: Nausea BBW: may cause hypoglycemia when used with insulin NOT used frequently
58
Lowers A1c 0.3-0.5% Also helps reduce LDL SE - constipation, dyspepsia, ↑ TG What am I? What is the recommendation?
Colesevelam (Welchol): Bile Acid Sequestrants Due to significant SE and only moderate effects on glucose, these are not recommended for primary tx of DM.
59
Lowers A1c 0.1-0.5% SE - N/V, dizziness, HA What am I? What is the recommendation?
Bromocriptine (Parlodel, Cycloset): Dopamine Receptor Agonists Due to significant SE and only moderate effects on glucose, these are not recommended for primary tx of DM
60
What is Soliqua a combination of? Xultophy? What is their limitation?
Soliqua - Insulin glargine (Lantus) + lixisenatide (Adlyxin) Xultophy - Insulin degludec (Tresiba) + liraglutide (Victoza) Max doses due to GLP-1 agonist component May not be enough insulin for poorly controlled diabetics
61
What are the glycemic control guidelines for non-pregnant adult pt? How often should they get their A1C checked?
q3 months if NOT well controlled q6 months if well controlled
62
What are some adjunct therapy options for T1DM?
Teplizumab (Tzield) - consider for early or pre-DM cases with high risk of T1DM Donislecel-jujn (Lantidra) - consider for refractory or severe T1DM
63
**_____ consider for early or pre-DM cases with high risk of T1DM
Teplizumab (Tzield)
64
_____ consider for refractory or severe T1DM
Donislecel-jujn (Lantidra)
65
_____ mimics the effects of endogenous glucagon. What form is used the most often?
Glucagon 3 mg intranasal
66
_____ provides body with monosaccharide fuel for metabolic processes. Cannot give if pt is allergic to _____
Dextrose corn
67
What is the management for preDM? What do you need to monitor for?
7% weight loss at least 150 minutes of moderate physical activity per week consider metformin (off-label use) GLP-1 agonists are used to tx obesity yearly visit to f/u on glycemic status screen for obesity, HTN, HLD
68
What is the management of T2DM?
weight loss, exercise, healthy eating medications (see other notecard)
69
What is the medication management guidelines for a T2DM pt?
At diagnosis - metformin + diet + exercise If A1c not at goal in 3 mo - metformin + another agent + diet + exercise If A1c not at goal in 3 mo - metformin + two other agents + diet + exercise If A1c not at goal in 3 mo - metformin + insulin +/- other agents + diet + exercise
70
When do you consider insulin as a rx treatment at diagnosis of T2DM?
Consider insulin therapy at onset if patient has a markedly elevated A1c (9.0% or higher) or if significant hyperglycemia s/s
71
If pt has ASCVD and T2DM, what medications are considered 1st line?
ASCVD - GLP-1 or SGLT2
72
If pt has heart failure and T2DM, what medications are considered 1st line?
HF - SGLT2
73
If pt has CKD and T2DM, what medications are considered 1st line?
CKD - SGLT2 or GLP-1
74
What 2 classes of DM meds are considered moderate efficacy? What are all the others considered?
moderate efficacy: DPP-4 and SGLT2 all others: high efficacy
75
Which DM meds have a risk of hypoglycemia? (4)
risk with sulfonylureas, meglitinides, pramlintide, insulin
76
Which 3 DM meds are associated with weight loss? weight neutral? weight gain?
loss: GLP-1 agonists and SGLT2 inhibitors, Pramlintide neutral: Metformin, DPP-4 inhibitors gain: Sulfonylureas, TZDs, insulins
77
Which 3 DM meds are considered the most affordable?
metformin, sulfonylureas, and TZDs
78
For a T2DM pt on insulin, how many units should their basal insulin be?
basal: 10 units
79

Endocrine (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions